US 7910131
Method of treating seizures using modified release formulations of oxcarbazepine
granted A61KA61K2800/56A61K31/55
Quick answer
US patent 7910131 (Method of treating seizures using modified release formulations of oxcarbazepine) held by Supernus Pharmaceuticals, Inc. expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2800/56, A61K31/55, A61K9/0073, A61K9/2013